Related Experiment Video
Updated: Aug 6, 2026

Use of a Hanging-weight System for Liver Ischemia in Mice
Published on: August 7, 2012
Blocking the path to death: anti-apoptotic molecules in ischemia/reperfusion injury of the liver
1Swiss Hepato-Pancreato-Biliary Centre, Department of Visceral and Transplantation Surgery, University Hospital of Zürich, Rämistrasse 100, 8091-Zürich, Switzerland.
Abstract:
This review highlights recent advances in our understanding of intracellular mechanisms underlying programmed cell death in hepatic ischemia/reperfusion injury. A range of molecules have been tested with the intention to block the pathways of programmed cell death at different levels and to thereby enhance viability of the liver in surgical procedures including liver transplantation. Cellular death receptors, the mitochondrial pathway of apoptosis, p53, mitogen-activated protein kinases (MAPKs) and intracellular proteases all present potential targets for pharmaceutical agents to prevent ischemia induced cell death in the liver. Although evidence has been provided for effective inhibition of injury and improvement of survival by such agents, an optimal treatment strategy remains to be developed.
Insights
Researchers explored programmed cell death in liver injury after ischemia/reperfusion. Targeting pathways like apoptosis and mitogen-activated protein kinases (MAPKs) shows promise for improving liver viability, though optimal treatments are still needed.
Area of Science:
- Hepatology
- Cellular Biology
- Transplantation Medicine
Background:
- Hepatic ischemia/reperfusion (I/R) injury is a significant complication in liver surgery and transplantation.
- Programmed cell death plays a critical role in the pathogenesis of liver I/R injury.
- Understanding intracellular mechanisms is key to developing protective strategies.
Purpose of the Study:
- To review recent advances in intracellular mechanisms of programmed cell death in hepatic I/R injury.
- To identify potential molecular targets for therapeutic intervention.
- To assess the efficacy of agents targeting these pathways.
Main Methods:
- Literature review of studies on programmed cell death in hepatic I/R injury.
- Analysis of molecular pathways including death receptors, mitochondrial apoptosis, p53, MAPKs, and proteases.
- Evaluation of preclinical and clinical data on therapeutic agents.
Main Results:
- Several molecular targets within programmed cell death pathways have been identified.
- Agents targeting these pathways have demonstrated potential in inhibiting injury and improving survival.
- Specific pathways like mitochondrial apoptosis and MAPKs are highlighted as crucial.
Conclusions:
- Targeting intracellular programmed cell death mechanisms offers a promising therapeutic avenue for hepatic I/R injury.
- Pharmaceutical agents show potential for enhancing liver viability during surgical procedures.
- Further research is needed to develop an optimal treatment strategy.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury IV: Necrosis
Cellular Injury V: Apoptosis and Autophagy
Cellular Injury IlI: Cellular Death
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
